Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03314584 · ClinicalTrials.gov registry record · NA

Managing Mild Traumatic Brain Injury Related Headaches With Repetitive Transcranial Magnetic Stimulation

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
179
Enrollment target

NCT03314584: Completed NA study, sponsored by VA Office of Research and Development.

NCT03314584 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 179 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03314584, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
179 participants
Enrollment target

Study Summary

Persistent headache is one of the most common debilitating symptoms in military personnel suffering from mild traumatic brain injury (MTBI). This study aims to assess the long-term effect of repetitive transcranial magnetic stimulation (rTMS) in managing MTBI related headaches for up to 2-3 months by comparing the treatment effect of active-rTMS to sham-rTMS.

Primary Outcome

The outcome measure will be quantified through the headache diary log that tracks the intensity, frequency and duration of MTBI-headaches (MTBI-HA). Baseline data includes all logs from the start of the study until the start of treatment. Post-intervention data looked at the time between the 3-month follow-up and the previous visit.

Interventions

  • DEVICE Transcranial Magnetic Stimulation
  • DIAGNOSTIC_TEST Magnetic resonance imaging (MRI)
  • DEVICE Sham Transcranial Magnetic Stimulation

Trial Details

FieldValue
Enrollment Target 179 participants
Start Date 2018-01-01
Est. Completion 2024-01-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03314584 record still lists

NCT03314584 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 3 interventions - of which Transcranial Magnetic Stimulation is the first listed.

NCT03314584 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03314584 about?

NCT03314584 is a clinical study titled "Managing Mild Traumatic Brain Injury Related Headaches With Repetitive Transcranial Magnetic Stimulation". Persistent headache is one of the most common debilitating symptoms in military personnel suffering from mild traumatic brain injury (MTBI). This study aims to assess the long-term effect of repetitive transcranial magnetic stimulation (rTMS) in managing MTBI related headaches for up to 2-3 months b...

What is the current status of trial NCT03314584?

This trial is currently completed. It is a NA study. The enrollment target is 179 participants. The study started on 2018-01-01. Estimated completion is 2024-01-31.

What interventions are being tested in trial NCT03314584?

The interventions under investigation include: Transcranial Magnetic Stimulation (DEVICE), Magnetic resonance imaging (MRI) (DIAGNOSTIC_TEST), Sham Transcranial Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT03314584?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03314584's enrollment target sits among peer trials

179 604th of 2000 higher than 1,397 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06581198 · 179 participants · Phase 2

    A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

  • NCT07356323 · 179 participants · NA

    A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03314584, the US trial registry maintained by the National Library of Medicine. NCT03314584 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.